Dietary Macronutrients and Gut Microbiota, Inflammation, and Metabolic Markers
NCT07672691 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-07-02
Summary
Poniżej znajduje się bardziej płynna i mniej powtarzalna wersja tekstu:
This 12-week randomized controlled trial will investigate the effects of dietary patterns with different macronutrient compositions on gut microbiota, intestinal inflammation, gene expression, and metabolic health in healthy adults.
Participants will be randomly assigned to one of three dietary interventions: a ketogenic diet (KD), a vegetarian diet (VD), or a control diet (CD) reflecting their habitual mixed dietary pattern. Adherence to the assigned diet will be monitored through dietary records and regular nutritional counseling.
The study will evaluate changes in gut microbiota composition, inflammatory biomarkers, transcriptomic profiles, and blood biochemical parameters associated with lipid and glucose metabolism. Blood and stool samples will be collected at predefined time points throughout the intervention, while participants in the KD group will additionally undergo ketone monitoring to assess dietary compliance.
By comparing the ketogenic and vegetarian diets with a standard mixed diet, this study aims to determine their effects on gut health, metabolic function, and systemic inflammation, thereby providing evidence to inform dietary recommendations.
Ta wersja eliminuje powtórzenia ("diet", "study", "monitor", "effects"), jest bardziej naturalna stylistycznie i odpowiada standardowi językowemu publikacji w czasopismach z zakresu żywienia i medycyny.
Conditions
- Nutrition
- Ketogenic Diet
- Gene Expression
- Diet
Interventions
- OTHER
-
Ketogenic Diet (KD)
Participants in the Ketogenic Diet Group (KD) will follow a strict ketogenic diet for 12 weeks. The ketogenic diet is characterized by: Fat intake: Approximately 70-80% of total daily energy Carbohydrate intake: Approximately 5-10% of total daily energy (typically \<50 g carbohydrates per day) Moderate protein intake: Approximately 15-20% of total daily energy Dietary Guidelines: Allowed foods: Fatty meats, fish, eggs, full-fat dairy products, butter, oils (olive oil, coconut oil, avocado oil), nuts, seeds, low-carbohydrate vegetables (e.g., leafy greens, broccoli, cauliflower), avocados Restricted foods: All grains (bread, pasta, rice, cereals), high-carbohydrate fruits (bananas, apples, oranges), starchy vegetables (potatoes, corn), legumes, sugar-sweetened foods and beverages, most processed foods Blood ketone levels will be measured once weekly by participants (morning, before breakfast) using a ketone meter (Optimum Xido) Duration: 12 weeks
- OTHER
-
Vegetarian Diet (VD)
Participants in the Vegetarin Diet Group (VD) will follow a plant-based vegetarian diet for 12 weeks. The vegetarin diet excludes all animal products and is characterized by: Macronutrient composition: Balanced intake of carbohydrates, proteins, and fats from plant sources Primary food sources: Vegetables, fruits, legumes (beans, lentils, peas), nuts, seeds, whole grains, plant-based oils Dietary Guidelines: Allowed foods: All vegetables, fruits, legumes, nuts, seeds, whole grains (rice, quinoa, oats, wheat), plant-based milks, tofu, tempeh, plant-based oils, avocados Restricted foods: All animal products including meat, poultry, fish, eggs, dairy products, honey, and any food containing animal-derived ingredients Dietary adherence will be monitored through regular food diaries and nutritional counseling sessions Participants will receive guidance on adequate protein intake, vitamin B12, iron, calcium, and omega-3 fatty acid supplementation if needed Duration: 12 weeks
- OTHER
-
Control Diet (CD)
Participants in the Control Diet Group (CD) will serve as the control group and will continue their current habitual mixed diet without specific dietary modifications for 12 weeks. Diet type: Habitual mixed diet (includes both plant and animal products) Macronutrient composition: No modifications; participants maintain their usual dietary intake No dietary restrictions or instructions: Participants are not instructed to change their eating patterns Monitoring: Dietary intake will be documented through regular food diaries Participants will attend visits with a dietitian at 4, 8, and 12 weeks for monitoring purposes only (no dietary changes instructed) Duration: 12 weeks
Sponsors & Collaborators
-
Jagiellonian University
collaborator OTHER -
Pomeranian Medical University Szczecin
collaborator OTHER -
The Jerzy Kukuczka Academy of Physical Education in Katowice
lead OTHER
Principal Investigators
-
Małgorzata M Michalczyk, Assistante professor · Institute of Sport Sciences, Jerzy Kukuczka Academy of Physical Education in Katowice
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-02
- Primary Completion
- 2024-09-03
- Completion
- 2028-12-30
Countries
- Poland
Study Locations
More Related Trials
-
Effects of Plant Foods on Gastrointestinal and Cardiometabolic Health
NCT07586111 ·Status: RECRUITING ·Phase: NA
-
Kefir Versus Milk on Time-Trial Performance in Masters Athletes
NCT06165523 ·Status: COMPLETED ·Phase: NA
-
Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia
NCT04837638 ·Status: ACTIVE_NOT_RECRUITING
-
Fiber Fermentation Study
NCT04570137 ·Status: COMPLETED ·Phase: NA
-
Effects of Milk-based Drinks on Gut Microbiome, Sleep and Cardiometabolic Markers
NCT07071181 ·Status: RECRUITING ·Phase: NA
-
A Culture-tailored Plant-based Dietary Intervention in Taiwan
NCT07728877 ·Status: COMPLETED ·Phase: NA
-
Effect of Consumption of a Novel Functional Yogurt on Blood Biomarkers of Healthy Participants
NCT05612243 ·Status: UNKNOWN ·Phase: NA
-
Effects of Kefir Consumption on Health Outcomes: Gastrointestinal System, Immunity, Biochemical Parameters, Body Composition, Sleep Quality and Mental Well Being in Healthy Adults
NCT06612164 ·Status: COMPLETED ·Phase: NA
-
The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers
NCT06082726 ·Status: COMPLETED ·Phase: NA
-
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
NCT03118583 ·Status: COMPLETED ·Phase: NA
-
Improving Health Outcomes With Kefir
NCT06695221 ·Status: RECRUITING ·Phase: NA
-
Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome
NCT02656056 ·Status: COMPLETED ·Phase: PHASE1
-
Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia.
NCT06389825 ·Status: COMPLETED ·Phase: NA
-
Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NCT06894004 ·Status: RECRUITING ·Phase: NA
-
Effect of a Vegan Diet Versus a Mediterranean Diet. Assessing Health Outcomes
NCT06008886 ·Status: COMPLETED ·Phase: NA
-
Soybean Based Diets and CVD Risk Factors
NCT00175097 ·Status: COMPLETED ·Phase: NA
-
Effect of a Kefir Beverage on Immunity and Lipid Profile
NCT03312660 ·Status: COMPLETED ·Phase: NA
-
Effect of The Substitution of Animal Protein by Soya-Based Fermented Product on Human Gut Microbiome
NCT06304480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Tomato Products and Disease Risk
NCT00966550 ·Status: COMPLETED ·Phase: NA
-
Diets, Lipoproteins and Inflammation Markers
NCT05423457 ·Status: COMPLETED ·Phase: NA
-
Physical and Chemical Study of Atherosclerosis Mechanisms
NCT01700075 ·Status: COMPLETED ·Phase: PHASE4
-
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
NCT00010829 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Low-Fat Compared to Low-Carbohydrate Diet in Subjects With Multifactorial Chylomicronemia
NCT03898609 ·Status: COMPLETED ·Phase: NA
-
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
NCT03429920 ·Status: COMPLETED ·Phase: NA
-
Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome
NCT03522974 ·Status: TERMINATED ·Phase: NA